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Abstract  
Background: Juvenile idiopathic arthritis (JIA) is a heterogenic group of chronic inflammatory 
connective tissue diseases of unknown aetiology in children up to 16 years of age. 
Aim: The aim of this study was to analyse the incidence, clinical presentation and laboratory 
findings in children with JIA in Malopolska region. 
Materials and methods: A retrospective analysis included all children with JIA (N=251) 
hospitalized in the two reference rheumatology centres covering Malopolska region (Poland), 
between July 2007 and December 2010. 
Results: The annual incidence of JIA in Malopolska region was estimated at 9.5 per 100 000 
children. Oligoarthritis (54.9%) was the most common category in all age groups with a tendency to 
decrease with age; from 71.4 % in children aged 1-6 years; 55.7% in aged 7-12 years to 39.3 % in 
aged 13-16 years. The frequency of polyarthritis and enthesitis-related arthritis was greater in 
adolescents (29.2 % and 22.5 %, respectively). HLA-B27 antigen and uveitis were most frequently 
found in children with enthesitis-related arthritis (58% and 18.5 %, respectively). 
Conclusions: The study suggests the improvement of diagnostic capacity of JIA during the last 
decade in Poland. In accordance with the existing data diverse clinical presentation of JIA 
categories and laboratory characteristics were proven. 
  
 
 
 
 
 
Introduction 
Juvenile idiopathic arthritis (JIA) is the most 
common chronic inflammatory arthropathy in 
developmental age. It represents a heterogeneous 
group of diseases of unknown aetiology characterized 
by the onset of symptoms of arthritis before the age of 
16 years, lasting for more than 6 weeks [1]. The 
current classification system by International League 
Against Rheumatism - ILAR (Edmonton 2001) 
distinguish seven JIA categories, characterized by 
different clinical presentation and laboratory findings, 
as well as the outcome [1]. The annual incidence of 
JIA is estimated at 2 to 20 cases per 100 000 children, 
with a prevalence of 16 to 150 cases per 100 000 
children worldwide, with no clear racial predilection 
[2]. In Poland, a decade ago, the incidence was 
estimated at 5 - 6.5 per 100 000 children, with almost 
twice higher numbers in girls (1.5-2:1), on the basis of 
data from Lodz and Kielce regions [3,4]. 
The aim of this study was to analyse the 
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incidence, clinical presentation and laboratory findings 
in children with JIA in Malopolska region. 
 
Material and Methods 
The retrospective analysis enrolled all 
children diagnosed with JIA in two reference 
rheumatology centres (Department of Paediatrics, 
Rheumatology and Environmental Diseases and 
Department of Older Children with subunits of 
Neurology, Rheumatology and Rehabilitation) 
covering Malopolska region between 1
st
 of July 2007 
and 31
st
 of December 2010. 
The study included all patients who met the 
diagnostic criteria of JIA by ILAR revised in 2001 (age 
less than 16 years, the duration of symptoms of 
arthritis for more than 6 weeks, exclusion of other 
causes of arthritis) [1]. The analysis excluded children 
diagnosed with infectious, reactive, toxic and allergic 
arthritis, proliferative diseases, and other inflammatory 
connective tissue diseases, arthropathies in 
haematological, immune and metabolic diseases, 
systemic non-inflammatory connective tissue 
diseases, psychogenic rheumatism (pain syndrome) 
and fibromyalgia. According to the current 
classification system seven categories of JIA were 
distinguished [1]. 
The analysis included the following clinical 
data retrieved from medical records: articular changes 
at the beginning of the disease, age of onset, duration 
of symptoms of arthritis (swollen joints) at the time of 
diagnosis (scored as patient referral to the reference 
rheumatology centre), auxological parameters, ocular 
changes, the therapy applied, and verification of the 
diagnosis after six months of illness, as well as 
laboratory tests results (erythrocytes sedimentation 
rate and serum levels of C-reactive protein at the 
admission to the referral centre, and the presence of 
antinuclear antibodies, anti-cyclic citrullinated peptide 
antibodies, rheumatoid factor, antigen HLA B27 
detected during 6 months follow-up).  
All patients were followed for at least 6 
months. Those with active disease are followed by the 
centers until adulthood. The study was approved by 
the Bioethics Committee in Cracow. 
Laboratory assessments were performed in 
certified laboratories. Reference values for C-reactive 
protein (CRP) was <10 mg/L, for anti-cyclic 
citrullinated peptide antibodies (anti-CCP) <5 RU/mL, 
and for rheumatoid factor (RF) <10.8 IU/mL.  
Antinuclear antibodies titre was measured by 
indirect immunofluorescence method followed by 
immunodiffusion (ImmunoBlott profil Euroline 3, 
Euroimmun, Poland). RF rheumatoid factor IgM were 
determined twice at an interval of 12 weeks, semi-
quantitatively by Waaler-Rose Test. Anti-CCP was 
assessed by ELISA kit from Euroimmun Polska 
(Wroclaw, Poland). Human leukocyte antigen B27 
(HLA-B27) was determined in peripheral lymphocytes 
by serotyping. 
 
Statistical analysis 
Statistical analyses were performed using the 
STATISTICA 10.0 PL for Windows software package 
(StatSoft Polska, Kraków, Poland) and MedCalc 
12.3.0.0. (Mariakerke, Belgium). Values are presented 
as means and 95% confidence intervals or medians 
with interquartile ranges. For comparison of groups, 
we used the chi
2
 test and chi
2
 test for trend (qualitative 
variables) and ANOVA, followed by Tukey’s test or 
ANOVA Kruskal-Wallis (quantitative variables). In all 
statistical tests the ‘p’ values below 0.05 were 
considered statistically significant. 
 
Results 
 
Patients characteristics’ 
Two-hundred-fifty-one children, all Cauca-
sians, were diagnosed with JIA between 1
st
 of July 
2007 and 31
st
 of December 2010. There were 138 
girls and 114 boys (ratio 1.2:1) in age from 1 to 16 
years (mean 9.5 year at the time of diagnosis). There 
was no patient excluded from the analysis. 
 
Table 1: Jjuvenile idiopathic arthritis (JIA) categories in 
analyzed population of Maloposka region. 
 
JIA categories Study population [N=251] 
 N (%) 
Systemic arthritis 22 (8.8) 
Oligoarthritis  138 (54.9) 
     Persistent course 130 (51.7) 
     Extended course 8 (3.2) 
     Uniarticular onset* 87 (35.0) 
Polyarthritis, rheumatoid factor positive  9 (3.6) 
Polyarthritis, rheumatoid factor negative 48 (19.1) 
Enthesitis-related arthritis 27 (10.8) 
Psoriatic arthritis 4 (1.6) 
Unclassified     3 (1.2) 
* category not included in ILAR classification. 
On the basis of the obtain data the annually 
incidence of JIA was estimated at 9.5 per 100 000 
children in Malopolska region, Poland (for the 
paediatric population of 758 213 – average value in 
years 2008-2010). 
 
JIA categories 
The incidence of JIA subtypes were shown in 
Table 1. The mean age of symptoms onset (arthritis) 
of JIA subtypes was significantly different (Table 2). 
Children with polyarthritis and enthesitis-related 
arthritis were significantly older than those with 
oligoarthritis (in 78% affecting the knee).  
The relationship between age and diagnosed 
JIA categories is better illustrated by Figure 1, with the  
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Table 2: Clinical and laboratory characteristics of the individual types of juvenile idiopathic arthritis. Data shown at mean values 
and 95% CI or median with interquartile range†. (NA – non applicable) 
 Systemic onset 
[N=22] 
Oligoarticular 
onset 
[N=138] 
Polyarticular 
onset 
[N=57] 
Enthesitis-related 
arthritis 
 
[N=27] 
Juvenile 
psoriatic 
arthritis 
[N=4] 
Unclassified 
course 
[N=4] 
ANOVA 
p 
Gender  
[f/m, ratio] 
11 / 11 
1:1 
81 / 57  
1.4:1 
35 / 22 
1.6:1 
8/ 19^^ 
1:2.4 
1 / 3 
- 
1 / 2 
- 
NA 
Age of JIA onset 
[years] † 
7.7 
(3.5 – 13.0) 
7.8 
(3.3 – 12.1) 
11.1^ 
(7.3 – 14.0) 
13.7^^^ 
(11.9 – 15.5) 
10.0 
(9.5 – 10.3) 
11.6 
(10.9 – 13.0) 
<0.001 
Duration of JIA symptoms at the time of 
diagnosis [months] † 
1.2**# 
(0.1 – 2.4) 
3.0 
(1.2 – 5.0) 
3.0 
(1.8 – 6.0) 
6.0* 
(3.0 – 9.6) 
6.0 
(1.2 – 12.0) 
5.2 
(3.0 – 6.9) 
0.005 
Uveitis 
[number, (%)] 
1 (4.5) 5 (3.6) 3 (5.3) 5 (18.5) 0 0 NA 
Sedimentation rate at admission 
[mm/h] 
87*** 
(73 – 100) 
29 
(24 – 33) 
39 
(30 – 48) 
24 
(15 – 33) 
38 
(0 – 128) 
35 
(0 – 100) 
<0.001 
SR >12 mm/h at admission 
[number, (%)] 
22 (100)^^^ 85 (61.6) 47 (82.5)^^ 13 (48.2) 2 (50) 2 (66.6) NA 
CRP at admission 
[mg/l] 
105.7*** 
(55.8 – 155.6) 
10.3 
(7.3 – 13.3) 
20.1 
(14.2 – 26.1) 
10.0 
(4.6 – 15.3) 
12.6 
(0 – 39.1) 
11.5 
(0 – 26.8) 
<0.001 
CRP > 10 mg/l at admission 
[number, (%)] 
21 (95.5)*** 31 (22.3) 30 (52.6)^^^ 8 (30.8) 1 (25) 2 (66.6) NA 
Rheumatoid factor 
[number of seropositive, (%)] 
0  1 (0.7) 9 (15.8) 0 0 0 NA 
Anti-nuclear antibodies 
[number of seropositive/tested, (%)] 
2/22 (9.1) 53/131 (40.5) 17/56 (30.4) 7/25 (28) 1/4 (25) 1/4 (25) NA 
HLA-B27  
[number/tested, %] 
1/13 (7.7) 24/103 (23.3) 12/37 (32.4) 15/26 (57.7) 1/4 (25) 0/4 NA 
^^^p<0.001, ^^p<0.01 ^p<0.05 vs. oligoarticular onset; #p<0.001 vs. enthesitis-related arthritis;  ***p<0.001, **p<0.01; *p<0.05 vs. oligoarticular onset as well as polyarticular onset. 
 
presentation of prevalence in age clusters. There is a 
clear, statistically significant, dominance of 
oligoarthritis among the youngest patients (71.4 % in 
the 1-6 years old subgroup) with a tendency to 
decrease with age (39.3 % in the 13-16 years old 
subgroup). On the contrary, enthesitis-related arthritis 
became more frequent in the oldest group. 
 
Figure 1: The incidence of the individual categories of juvenile 
idiopathic arthritis in age groups. P-values for chi
2 
for trend in 
subsequent age categories for the incidence of oligoarthritis, 
polyarthritis and enthesitis-related arthritis. 
 
The duration of symptoms established before 
the diagnosis was presented in the Table 2. Patients 
with systemic arthritis had the shortest history of 
symptoms at the time of diagnosis (median value 1.2 
months; p < 0.05), which is the consequence of acute 
clinical presentation resulting in the immediate 
hospitalization. It took much longer to diagnose 
children with enthesitis-related arthritis - 6 months in 
average. They were frequently initially misdiagnosed 
as avascular necrosis or degenerative disc disease. 
Laboratory findings 
Analysis of markers of inflammation (CRP, 
ESR) at the admission to the referral centre, revealed 
a statistically significant increase in the ESR in 
subgroup with systemic arthritis, than in the patients 
with oligoarthritis and polyarthritis. Increased values of 
ESR and CRP (ESR > 12 mm/h; CRP > 10 mg/l) were 
shown in 100% and 95.5% of children with systemic 
arthritis, respectively. Higher levels of inflammatory 
markers at the referral were also showed in patients 
with polyarthritis than oligoarthritis (Table 2). 
 
Rheumatic factor (RF) and anti-CCP 
The frequency of patients seropositive for RF 
(assessed in all patients) is presented in Table 2. Anti-
CCP antibodies were assessed in 101 patients, 
mostly in those with polyarthritis (N=29) and 
oligoarthritis (N=50). 
There were 9 patients (8 females) RF 
seropositive (15.8%), including 6 seropositive and 3 
seronegative for anti-CCP among children with 
oligoarthritis. Additionally, in one RF seronegative 
patient with oligoarthritis anti-CCP antibodies were 
detected.  
 
Antinuclear antibodies (ANA) 
The presence of ANA (in titter > 1:160) were 
found in 81 patients out of 241 tested (32.3% of 
cases), most frequently in those with oligoarthritis 
(40.5% of all; 44.9% of females and 34% of males). 
ANA were also frequently detected in patients with 
polyarthritis (30.4%) and enthesitis-related arthritis 
(28%) – Table 2. 
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HLA B27 
The antigen HLA B27 was found in 53 of 186 
tested patients - 28.5% (Table 2). Most frequently 
HLA-B27 antigen was present in patients with 
enthesitis-related arthritis – 57.7%, polyarthritis - 
32.4%, and oligoarthritis – 23.3%. On the bases of the 
5.3% prevalence of HLA-B27 among 400 blood 
donors in Poland [5],
 
we estimated odds ratios (OR) 
for JIA subtypes at: 24.6 (95% CI 10.1 - 60.1) for 
enthesitis-related arthritis, 8.7 (3.8 - 19.6) for 
polyarthritis and 5.5 (2.9 - 10.3) for oligoarthritis. 
 
Uveitis 
Ophthalmological examination was performed 
in all of the 251 analysed patients. Fourteen patients 
were diagnosed with uveitis (5.6% of the study group). 
This symptom was observed usually in patients with 
oligoarthritis and enthesitis-related arthritis (Table 2). 
14.3% of children with uveitis were seropositive for 
ANA, and 64.3% had HLA-B27 antigen. Patients with 
uveitis and HLA-B27 antigen were older (median age 
of JIA onset 13.5 yrs.) than ANA-seropositive patients 
without HLA-B27 antigen (median age of JIA onset 
5.4 yrs.). 
 
Seasonality of JIA 
The result of the seasonal incidence of JIA 
cases in the Malopolska population is presented in 
Figure 2. The onset of oligoarthritis occurred most 
frequently in spring and autumn, while less frequently 
during winter and summer (the differences were not 
statistically significant). No seasonality was 
demonstrated for enthesitis-related arthritis. 
 
Figure 2: Seasonality of incidence of JIA categories.  
 
 
Discussion 
Our study estimated the current incidence of 
JIA at 9.5 per 100 000 children, almost 2-fold greater 
than has been shown about a decade ago for the 
region of Lodz and Kielce (5-6.5 per 100 000) [3, 4]. 
The obtained data suggest rather the improvement in 
the diagnostic capacity of JIA in our country, than the 
increasing incidence of the disease. 
Numbers reported by us are slightly lower 
than in Nordic countries - 15 per 100 000 
children/year [6], but greater than in Alsace (France) - 
3.2 per 100 000/year in children under age 16 years 
[7].  
The structure of the subtypes of JIA is almost 
in line with the register of British Paediatric 
Rheumatology Group. Only the incidence of juvenile 
psoriatic arthritis was lower (1.6% vs. 7.0%). The lack 
of inclusion of unclassified arthritis in BRRG register 
cannot explain the difference [8, 9]. The lower 
prevalence of juvenile psoriatic arthritis in our group of 
patients could be explained by heterogeneous clinical 
feature of this entity [10], also influenced by the 
applied therapy, that might cause its misclassification 
as other JIA category. 
Oligoarthritis accounted for about 40%of JIA 
cases in France [7], 50% in United Kingdom [8,9] and 
54% in Estonia [11]. Not only in European countries 
but also in other continents, oligoarthritis is the most 
common JIA category among Caucasians [12].  
Our data confirm the differences in the clinical 
and laboratory characteristics of JIA categories, which 
do not have in many aspects, a counterpart in 
adulthood, and still rising controversies, being a 
subject of debate on the revision of the nomenclature 
and classification of JIA [13]. 
The clinical and laboratory characteristics of 
JIA patients with systemic arthritis showed gender 
equality (ratio 1:1) typical for this entity, high levels of 
inflammatory markers, and the presence of ANA only 
in a small subset of patients (9%). The diversity of this 
category is probably due to the autoimmune 
pathogenesis, that is a key element in the discussion 
concerning the necessity of revision of the current JIA 
classification and its separation as individual entity, 
the equivalent of Still's disease in adults. It is worth 
noting that originally, JIA with the systemic onset was 
named Still’s disease.  
The most common category of JIA in our 
study was oligoarthritis, diagnosed in 54.9 % of 
children, 1.4-time more frequent in girls. Initially, the 
disease frequently involves single large joint: knee, 
ankle, elbow, wrist. It was also true for our population. 
The uniarticular symptomatology was presented by 
63% of patients, usually affecting the knee (78%). The 
laboratory profile confirmed relatively low severity of 
inflammatory reaction at the initial presentation. 38% 
were ANA seropositive, more predominantly girls 
(1.9:1). We showed increased frequency of HLA-B27 
(23.3 %) in this category and uveitis in 4% of patients. 
As it is well known, the clinical course of oligoarthritis 
is heterogeneous. In some cases the disease is 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
   60                                                                                                                                                                                                                      http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
evolving to rheumatoid arthritis (RF seropositive and 
more frequently seronegative), while in the other 
patients is leading to inflammatory spondylo-
arthropathy with initial peripheral manifestation. 
Another analysed JIA category – polyarthritis, 
diagnosed in 22.7% of patients, included mostly RF 
seronegative cases (84%). RF seropositive disease 
occurs usually in adolescents, presents with erosive 
changes and bone deformities, and corresponds to 
rheumatoid arthritis in adults. In this subgroup 52.6% 
patients had increased CRP and 82.5% ESR at 
admission to the reference centre. Almost one third of 
patients were seropositive for ANA, and HLA B27 
antigen was found in 32.4% of affected, 8 times more 
frequently than in the general population.  
Enthesitis-related arthritis accounted for 
10.8% of all JIA cases, and as expected was 2.4 
times more often among boys, mostly adolescents, 
with frequent prevalence of HLA B27 antigen (in 58% 
of patients). It can be estimated that HLA B27 antigen 
is increasing the risk for development of enthesitis-
related arthritis by 25 times. Additionally, in 18.5% of 
patients uveitis was diagnosed. The subgroup with 
enthesitis-related arthritis was characterized by the 
longest history of symptoms at the time accurate 
diagnosis was established - 6 months in average. 
Initially, due to nonspecific tendon pain, the patients 
are frequently misdiagnosed with avascular necrosis 
or degenerative disc disease. The disease affects, in 
addition to the Achilles tendon and plantar 
aponeurosis, attachment of patellar ligament at the 
tibial tuberosity, and attachments of deep back 
muscles. The family history of HLA B27 related 
disease, peripheral joint involvement, and the 
presence of the antigen shorten the period to the 
accurate diagnosis. 
Juvenile psoriatic arthritis was a sparse 
category of JIA in the study population (1.4%). Even 
such a small group (3 boys and 1 girl) had typical for 
this category characteristics - later onset (median age 
of 10 years), low intensity of inflammation, the 
absence of RF and anti-CCP antibodies.  
This study shows that the JIA population of 
children in Malopolska region has similar clinical 
presentation and laboratory profile as observed in 
other European affected populations [2, 9]. The delay 
in the proper diagnosis and initiation of adequate 
therapy in children with the other JIA categories than 
systemic arthritis, still rising concern. The time to 
diagnosis needs to be shorten below 6 months by 
increasing public awareness, especially in rural areas, 
as well as the knowledge of paediatricians. Only early 
referral of patients with symptoms of JIA to 
rheumatologists and not to orthopaedists (despite the 
absence of a history of trauma) may improve the 
current situation. 
An interesting finding presented in the study is 
the seasonality of JIA. The strongest seasonality of 
the incidence was found in the group of children 
suffering from oligoarthritis. The lower incidence of JIA 
was reported in winter and summer months. The 
increase in the occurrence in spring and autumn 
overlap with the peak incidence of infections, and is in 
line with hypotheses emphasising the role of 
infectious factors as triggering mechanism in 
predisposed individuals. As the analysis was 
underpowered and based on self-reported data, a 
potential bias cannot be excluded. Small children 
report the onset of symptoms not very accurately, 
while parents frequently wrongly interpret children’s 
complains and seek medical advice with a delay. 
Our study has some limitations. The incidence 
of JIA may be underestimated, as we could not 
exclude that some children living in the distant sites in 
the region were refereed to neighbouring regions. In 
our opinion the number of such cases was low, if any. 
Conclusions: The study suggests the 
improvement of diagnostic capacity of JIA during the 
last decade in Poland. In accordance with the existing 
data diverse clinical presentation of JIA categories 
and laboratory characteristics were proven. 
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